HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenichi Takeshita Selected Research

Disease Progression

9/2021A Case Report of Bacterial Meningitis Caused by an Emerging Strain of Penicillin-Resistant Non-Vaccine Serotype 10A.
11/2009Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's Lymphoma.
5/2009Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma.
10/2008Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.
12/2006Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase II study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenichi Takeshita Research Topics

Disease

5Disease Progression
09/2021 - 12/2006
4Pneumococcal Infections
01/2023 - 09/2021
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2017 - 11/2005
3Hematologic Neoplasms (Hematological Malignancy)
09/2020 - 10/2008
3Neoplasms (Cancer)
10/2017 - 12/2006
3Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2009 - 12/2005
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2017 - 05/2009
2Lymphoma (Lymphomas)
10/2008 - 05/2004
1Meningitis
10/2022
1Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis)
01/2022
1Common Variable Immunodeficiency
12/2021
1Primary Immunodeficiency Diseases
12/2021
1Agammaglobulinemia (Hypogammaglobulinemia)
12/2021
1Bacterial Meningitis
09/2021
1Abscess
09/2021
1Rubella (German Measles)
01/2021
1Measles
01/2021
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2020
1Fatigue
01/2020
1Infections
04/2016
1Burkitt Lymphoma (Burkitt's Lymphoma)
01/2012
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2012
1Multiple Myeloma
07/2010
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2009
1Neutropenia
10/2009
1Thrombocytopenia (Thrombopenia)
10/2009
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2009
1Chromosome Aberrations (Chromosome Abnormalities)
10/2009
1Anemia
10/2009
1Acquired Immunodeficiency Syndrome (AIDS)
05/2004

Drug/Important Bio-Agent (IBA)

8Lenalidomide (CC 5013)FDA Link
01/2020 - 12/2006
5Conjugate VaccinesIBA
01/2023 - 09/2021
3VaccinesIBA
10/2022 - 01/2021
3Rituximab (Mabthera)FDA Link
01/2012 - 12/2005
2Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 09/2021
1Toll-Like Receptors (Toll-Like Receptor)IBA
12/2021
1Immunoglobulin A (IgA)IBA
12/2021
1Immunoglobulin G (IgG)IBA
12/2021
1Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
10/2021
123-valent pneumococcal capsular polysaccharide vaccineIBA
10/2021
1Penicillins (Penicillin)FDA Link
09/2021
1Rubella VaccineIBA
01/2021
1AntibodiesIBA
09/2020
1Polysaccharides (Glycans)IBA
09/2020
1Phosphates (Orthophosphate)IBA
09/2020
1spebrutinibIBA
10/2017
1Agammaglobulinaemia Tyrosine KinaseIBA
10/2017
1Micafungin (FK463)FDA Link
04/2016
1Voriconazole (Vfend)FDA LinkGeneric
04/2016
1Dexamethasone (Maxidex)FDA LinkGeneric
07/2010
1Complement System Proteins (Complement)IBA
12/2005
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2005
1fludarabineIBA
11/2005
1Thalidomide (Thalomid)FDA Link
11/2005
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2005

Therapy/Procedure

6Therapeutics
01/2020 - 11/2005
1Induction Chemotherapy
01/2020
1Drug Therapy (Chemotherapy)
01/2012
1Oral Administration
10/2009
1Highly Active Antiretroviral Therapy (HAART)
05/2004